Patients taking imatinib (Gleevec) for CML, or chronic myelogenous leukemia, and in remission after two years of treatment, have a mortality rate similar to that of the general population according to a study published online ...
Mar 22, 2011
not rated yet
0
Researchers at Duke University Medical Center have identified a mechanism that could explain how patients move into the worst phase of chronic myelogenous leukemia (CML).
Jul 18, 2010
4.7 / 5 (3)
0
| 
New research discovers a combination of drugs that may prove to be a more effective treatment for a lethal form of leukemia. The study, published by Cell Press in the May issue of the journal Cancer Cell, reports that the ne ...
May 17, 2010
not rated yet
0
An international team of scientists studying acute forms of Leukaemia have identified a new drug target to inhibit the genes which are vital for the growth of diseased cells. The research, reported in EMBO Molecular Medicine, reveal ...
Mar 03, 2010
not rated yet
0
(AP) -- Five scientists have won prestigious research awards for developing a life-saving leukemia treatment and for advances in "reprogramming" DNA, which led to a new kind of stem cell.
Sep 14, 2009
5 / 5 (1)
0
A molecular signature that helps account for the aggressive behavior of a variety of cancers such as pancreatic, breast and melanoma may also predict the likelihood of successful treatment with a particular anti-cancer drug. ...
Sep 06, 2009
5 / 5 (1)
1
In a discovery that rebuffs conventional scientific thinking, researchers at Georgetown University Medical Center (GUMC) have discovered a novel way to block the activity of the fusion protein responsible for Ewing's sarcoma, ...
Jul 05, 2009
not rated yet
0
Data showing the ability of omacetaxine to kill leukemic stem cells in mouse models with drug-resistant chronic myelogenous leukemia (CML) are the subject of an advance online publication in the journal Leukemia, ChemGenex Pharma ...
Mar 26, 2009
not rated yet
0
